Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 4 | 2025 | 693 | 0.760 |
Why?
|
Glucosylceramidase | 2 | 2024 | 27 | 0.640 |
Why?
|
Cathepsin D | 1 | 2017 | 16 | 0.580 |
Why?
|
Organic Anion Transporters | 1 | 2017 | 16 | 0.580 |
Why?
|
Acid Ceramidase | 1 | 2017 | 5 | 0.580 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2017 | 42 | 0.570 |
Why?
|
Symporters | 1 | 2017 | 69 | 0.550 |
Why?
|
Intellectual Disability | 5 | 2024 | 1056 | 0.400 |
Why?
|
Receptors, Cell Surface | 3 | 2009 | 469 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 5 | 2025 | 3153 | 0.390 |
Why?
|
Myelin Proteins | 2 | 2009 | 75 | 0.330 |
Why?
|
Syndrome | 5 | 2024 | 1119 | 0.330 |
Why?
|
Nervous System Malformations | 2 | 2022 | 130 | 0.330 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2009 | 6 | 0.320 |
Why?
|
Exome | 6 | 2024 | 1034 | 0.300 |
Why?
|
Central Nervous System | 1 | 2009 | 253 | 0.280 |
Why?
|
Seizures | 2 | 2024 | 874 | 0.270 |
Why?
|
Mutation | 6 | 2022 | 5826 | 0.270 |
Why?
|
Genetic Variation | 4 | 2024 | 1497 | 0.250 |
Why?
|
Chaperonin Containing TCP-1 | 1 | 2024 | 8 | 0.240 |
Why?
|
Mutation, Missense | 3 | 2019 | 876 | 0.230 |
Why?
|
Williams Syndrome | 1 | 2024 | 39 | 0.230 |
Why?
|
Dynamins | 3 | 2019 | 38 | 0.230 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2019 | 541 | 0.230 |
Why?
|
Protein Folding | 1 | 2024 | 216 | 0.220 |
Why?
|
Haploinsufficiency | 1 | 2025 | 258 | 0.210 |
Why?
|
Vulnerable Populations | 1 | 2024 | 140 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 378 | 0.200 |
Why?
|
Zebrafish | 1 | 2024 | 384 | 0.190 |
Why?
|
GTP Phosphohydrolases | 3 | 2019 | 143 | 0.190 |
Why?
|
Nuclear Proteins | 2 | 2019 | 1265 | 0.190 |
Why?
|
Aniridia | 1 | 2021 | 12 | 0.180 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 34 | 0.180 |
Why?
|
Zika Virus | 1 | 2022 | 143 | 0.180 |
Why?
|
Cerebellar Ataxia | 1 | 2021 | 66 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2021 | 778 | 0.170 |
Why?
|
Introns | 1 | 2021 | 299 | 0.170 |
Why?
|
Zika Virus Infection | 1 | 2022 | 170 | 0.170 |
Why?
|
eIF-2 Kinase | 1 | 2020 | 35 | 0.170 |
Why?
|
Peroxisomes | 2 | 2019 | 36 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 59 | 0.160 |
Why?
|
Drosophila melanogaster | 3 | 2025 | 771 | 0.160 |
Why?
|
Microcephaly | 1 | 2022 | 330 | 0.160 |
Why?
|
Case-Control Studies | 3 | 2025 | 3281 | 0.160 |
Why?
|
Mitochondria | 3 | 2022 | 682 | 0.150 |
Why?
|
Optic Atrophy, Autosomal Dominant | 1 | 2018 | 9 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 2 | 2018 | 244 | 0.150 |
Why?
|
Mitochondrial Proteins | 2 | 2018 | 229 | 0.150 |
Why?
|
Mitochondrial Dynamics | 1 | 2018 | 45 | 0.140 |
Why?
|
Developmental Disabilities | 2 | 2020 | 712 | 0.140 |
Why?
|
Genetic Testing | 1 | 2024 | 1000 | 0.140 |
Why?
|
Lysosomal Storage Diseases | 1 | 2017 | 36 | 0.140 |
Why?
|
Phenotype | 6 | 2024 | 4256 | 0.140 |
Why?
|
Genotyping Techniques | 1 | 2017 | 103 | 0.140 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 170 | 0.130 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 96 | 0.130 |
Why?
|
Brain Diseases | 1 | 2019 | 299 | 0.130 |
Why?
|
Humans | 24 | 2025 | 124610 | 0.130 |
Why?
|
Tenascin | 1 | 2016 | 31 | 0.130 |
Why?
|
Male | 14 | 2025 | 61198 | 0.130 |
Why?
|
Autistic Disorder | 1 | 2019 | 343 | 0.120 |
Why?
|
Brain | 2 | 2024 | 2983 | 0.120 |
Why?
|
Parkinsonian Disorders | 1 | 2016 | 75 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 209 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 249 | 0.110 |
Why?
|
Abnormalities, Multiple | 1 | 2020 | 959 | 0.110 |
Why?
|
GPI-Linked Proteins | 3 | 2009 | 100 | 0.110 |
Why?
|
Female | 13 | 2025 | 66492 | 0.110 |
Why?
|
Adult | 8 | 2024 | 29437 | 0.110 |
Why?
|
Disease Models, Animal | 1 | 2024 | 4352 | 0.110 |
Why?
|
Spasms, Infantile | 1 | 2016 | 171 | 0.110 |
Why?
|
Alleles | 4 | 2021 | 1615 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 1 | 2017 | 443 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 481 | 0.110 |
Why?
|
Chromatin | 1 | 2016 | 551 | 0.110 |
Why?
|
Histones | 1 | 2016 | 526 | 0.100 |
Why?
|
Nogo Receptor 1 | 2 | 2009 | 9 | 0.100 |
Why?
|
Aged | 5 | 2025 | 19702 | 0.100 |
Why?
|
Genotype | 1 | 2017 | 2556 | 0.090 |
Why?
|
Cohort Studies | 2 | 2017 | 4795 | 0.090 |
Why?
|
Animals | 9 | 2025 | 34087 | 0.090 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 1684 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 1758 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 43 | 0.080 |
Why?
|
Prosencephalon | 1 | 2009 | 39 | 0.080 |
Why?
|
Neurites | 1 | 2009 | 42 | 0.080 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 169 | 0.080 |
Why?
|
Heart Defects, Congenital | 1 | 2020 | 1813 | 0.080 |
Why?
|
Middle Aged | 4 | 2024 | 26713 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2008 | 60 | 0.070 |
Why?
|
Infant | 5 | 2024 | 12468 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2008 | 80 | 0.070 |
Why?
|
Nerve Regeneration | 1 | 2008 | 78 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 822 | 0.070 |
Why?
|
Transfection | 1 | 2009 | 1062 | 0.070 |
Why?
|
Myelin Sheath | 1 | 2008 | 121 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2009 | 526 | 0.070 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6533 | 0.070 |
Why?
|
Binding Sites | 1 | 2009 | 1295 | 0.060 |
Why?
|
Adolescent | 5 | 2024 | 19277 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 1231 | 0.060 |
Why?
|
Child, Preschool | 4 | 2024 | 14009 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2009 | 1005 | 0.060 |
Why?
|
Rats | 2 | 2009 | 3677 | 0.060 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 273 | 0.060 |
Why?
|
Replication Protein C | 1 | 2024 | 6 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 311 | 0.060 |
Why?
|
Neurons | 2 | 2017 | 1957 | 0.060 |
Why?
|
Synapses | 1 | 2008 | 455 | 0.060 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 124 | 0.060 |
Why?
|
Protein Subunits | 1 | 2024 | 164 | 0.060 |
Why?
|
alpha-Synuclein | 1 | 2025 | 122 | 0.050 |
Why?
|
Zebrafish Proteins | 1 | 2024 | 113 | 0.050 |
Why?
|
Loss of Function Mutation | 1 | 2024 | 149 | 0.050 |
Why?
|
Medically Underserved Area | 1 | 2024 | 89 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 2705 | 0.050 |
Why?
|
Caenorhabditis elegans | 1 | 2024 | 224 | 0.050 |
Why?
|
Proteome | 1 | 2024 | 243 | 0.050 |
Why?
|
CRISPR-Cas Systems | 1 | 2024 | 253 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 3554 | 0.050 |
Why?
|
Facies | 1 | 2021 | 153 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2021 | 100 | 0.040 |
Why?
|
Drosophila | 1 | 2025 | 782 | 0.040 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 18 | 0.040 |
Why?
|
Fibroblasts | 1 | 2024 | 882 | 0.040 |
Why?
|
Child | 4 | 2024 | 24372 | 0.040 |
Why?
|
Whole Genome Sequencing | 1 | 2021 | 280 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2025 | 716 | 0.040 |
Why?
|
Germ Cells | 1 | 2020 | 194 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 63 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 793 | 0.040 |
Why?
|
Muscles | 1 | 2019 | 289 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2024 | 606 | 0.040 |
Why?
|
Ataxia | 1 | 2020 | 169 | 0.040 |
Why?
|
Transcriptome | 1 | 2024 | 952 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 4409 | 0.040 |
Why?
|
Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
White Matter | 1 | 2020 | 178 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 9013 | 0.040 |
Why?
|
Heterozygote | 1 | 2019 | 672 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 203 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2017 | 189 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 166 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2017 | 220 | 0.030 |
Why?
|
Lysine | 1 | 2016 | 194 | 0.030 |
Why?
|
Genomics | 1 | 2024 | 1503 | 0.030 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 314 | 0.030 |
Why?
|
Muscle Hypotonia | 1 | 2016 | 187 | 0.030 |
Why?
|
Face | 1 | 2016 | 179 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 2016 | 177 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2017 | 744 | 0.030 |
Why?
|
Risk | 1 | 2017 | 755 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 658 | 0.030 |
Why?
|
Protein Domains | 1 | 2016 | 237 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 267 | 0.030 |
Why?
|
Disease Management | 1 | 2017 | 523 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2017 | 8191 | 0.030 |
Why?
|
Phosphorylation | 1 | 2017 | 1615 | 0.030 |
Why?
|
Mice | 3 | 2017 | 17639 | 0.030 |
Why?
|
Cell Line | 1 | 2017 | 2750 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 1605 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 657 | 0.020 |
Why?
|
Length of Stay | 1 | 2017 | 1310 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2016 | 1022 | 0.020 |
Why?
|
Risk Factors | 1 | 2025 | 10269 | 0.020 |
Why?
|
Prognosis | 1 | 2019 | 4624 | 0.020 |
Why?
|
Texas | 1 | 2017 | 3584 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2016 | 3732 | 0.020 |
Why?
|
Nogo Receptor 2 | 1 | 2008 | 1 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 2045 | 0.020 |
Why?
|
Nogo Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
Growth Cones | 1 | 2008 | 16 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 2008 | 38 | 0.020 |
Why?
|
Receptors, Peptide | 1 | 2008 | 50 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 275 | 0.020 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2008 | 131 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 383 | 0.020 |
Why?
|
Signal Transduction | 1 | 2017 | 4505 | 0.020 |
Why?
|
Protein Binding | 1 | 2008 | 1738 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 3040 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 16316 | 0.010 |
Why?
|